Target intelligence / Profile preview

Platinum–DNA crosslink (carboplatin-induced)

Molecular classification
Other (DNA lesion/adduct, not a protein or classic molecular target)
01

Overview

The platinum–DNA crosslink induced by carboplatin is a DNA lesion formed when the platinum atom in carboplatin covalently binds to DNA, typically at the N7 site on guanine bases. Carboplatin primarily creates intrastrand crosslinks but can also induce interstrand crosslinks, which are especially cytotoxic as they block separation of the DNA strands, preventing replication and transcription. These DNA crosslinks trigger the cellular DNA damage response, leading to cell cycle arrest and apoptosis—primary mechanisms of chemotherapy-induced tumor cell death. This process is a major mechanism for the anticancer effects of carboplatin and related platinum drugs, but it is not a discrete molecular entity or classic 'target' like a receptor or enzyme.

Other names
Platinum–DNA adduct (carboplatin)Carboplatin–DNA crosslinkCarboplatin-induced DNA interstrand crosslink
02

Mechanism of action

Formation of DNA interstrand and intrastrand crosslinks through covalent binding of platinum to DNA (primarily at the N7 position of guanine). Crosslinking blocks DNA replication and transcription, leading to cell cycle arrest and apoptosis.

03

Biological functions

Inhibition of DNA replicationInduction of apoptosis (cell death) due to DNA damageCell cycle arrest
04

Disease associations

Cancer (specifically as a therapeutic effect in chemotherapy)
05

Safety considerations

Myelosuppression (dose-limiting toxicity: neutropenia, thrombocytopenia)Secondary malignancies (long-term risk due to DNA damage)Renal toxicity (less for carboplatin than cisplatin)Risk of resistance (tumor cells with enhanced DNA repair are less susceptible)
06

Interacting drugs

Carboplatin

2 more in the full profile.

07

Biomarkers

Degree of DNA crosslinking in patient cells (e.g., measured by tail moment in comet assays)Mutational signatures associated with platinum damage (explored in research, not routine clinical practice)

Beyond the preview

Go deeper on Platinum–DNA crosslink (carboplatin-induced).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platinum–DNA crosslink (carboplatin-induced).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call